Polyester nanomedicines for visceral leishmaniasis treatment

Mohini Sikarwar; Vaishali Sunil Mishra; Preeti Tiwari; Madhu Gupta; Sunny Dholpuria; Piyush Kumar Gupta

doi:10.2217/nnm-2023-0215

Polyester nanomedicines for visceral leishmaniasis treatment

Nanomedicine (Lond). 2023 Sep;18(22):1515-1518. doi: 10.2217/nnm-2023-0215. Epub 2023 Sep 19.

Authors

Mohini Sikarwar^{1

2}, Vaishali Sunil Mishra^{1

2}, Preeti Tiwari³, Madhu Gupta⁴, Sunny Dholpuria⁵, Piyush Kumar Gupta^{1

2

6}

Affiliations

¹ Department of Life Sciences, Sharda School of Basic Sciences and Research, Sharda University, Greater Noida, Uttar Pradesh, 201310, India.
² Centre for Development of Biomaterials, Sharda University, Greater Noida, Uttar Pradesh, 201310, India.
³ Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India.
⁴ School of Pharmaceutical Sciences, Department of Pharmaceutics, Delhi Pharmaceutical Sciences & Research University, Pushp Vihar, Sector 3, MB Road, New Delhi, 110017, India.
⁵ Department of Life Sciences, JC Bose University of Science and Technology, YMCA, Faridabad, Haryana, 121006, India.
⁶ Department of Biotechnology, Graphic Era Deemed to be University, Dehradun, Uttarakhand, 248002, India.

PMID: 37724503
DOI: 10.2217/nnm-2023-0215

Abstract

Tweetable abstract Unveiling the power of polyester nanomedicines in revolutionizing visceral leishmaniasis treatment with enhanced drug loading and precise targeting.

Keywords: drug delivery; leishmaniasis; nanomedicine; neglected diseases; polyester.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Drug Carriers / therapeutic use
Drug Delivery Systems*
Humans
Leishmaniasis, Visceral* / drug therapy
Nanomedicine

Substances

Drug Carriers

Grants and funding

SRG/2022/000395/Science and Engineering Research Board